Disposable aerosol generator system and methods for administering the aerosol

Information

  • Patent Grant
  • 6799572
  • Patent Number
    6,799,572
  • Date Filed
    Friday, December 22, 2000
    24 years ago
  • Date Issued
    Tuesday, October 5, 2004
    20 years ago
Abstract
A disposable aerosol generator for use with an inhaler device which includes a heater adapted to volatilize fluid stored in the disposable aerosol generator and method of using the inhaler. The disposable body includes a sealed chamber and an outlet, the chamber being located between first and second layers of material. The chamber holds a predetermined volume of a fluid which is expelled through the outlet when the fluid in the chamber is volatilized by the heater. The disposable body can include a series of spaced apart aerosol generators, each of which can be advanced to a release position at which the heater can heat one of the fluid containing chambers. Prior to heating the fluid, the outlet can be formed by severing the first and/or second layer with a piercing element and the volatilized fluid can be expelled from the outlet into a passage of a dispensing member.
Description




BACKGROUND OF THE INVENTION




1. Field of the Invention




The present invention relates to an apparatus, system and methods of administering a fluid such as a medicated fluid in metered amount such as a unit dose to treat respiratory ailments. In particular, the invention relates to disposable aerosol generators, wherein the aerosols are generated via vaporization.




2. Description of Related Art




Aerosols are useful in a variety of applications including treatment of respiratory ailments. Various techniques for generating aerosols are disclosed in U.S. Pat. Nos. 4,811,731; 4,627,432; 5,743,251; and 5,823,178.




In particular, two distinct methods for delivery of medicated fluid in the form of an aerosol have been developed. In accordance with one method, a pharmaceutically active drug is dispensed in a low boiling point propellant (e.g., chloro-fluoro-carbon (CFC) or (HFA)) loaded in a pressurized canister from which the drug/propellant formulation may be released by the use of a device generally known as a metered dose inhaler. Once released the propellant evaporates and particles of the drug are inhaled by the patient. The other method involves the use of a nebulizer which creates an inhalable mist of fine particles from a solution or suspension of a drug. Both methods are hindered by significant problems relating to administering the proper dose.




In drug delivery applications, it is typically desirable to provide an aerosol having average mass median particles diameter of less than 2 microns to facilitate deep lung penetration. Additionally, it is desirable, in certain drug applications, to deliver medicaments at high flow rates (i.e., above 1 milligram per second). Devices for controlling the flow rate of an aerosol are known. For example, U.S. Pat. No. 4,790,305 concerns controlling the particle size of a metered dose of aerosol for delivery to the walls of bronchi and bronchioles by filling a first chamber with medication and a second chamber with air such that all of the air is inhaled prior to the inhaling of medication, and using flow control orifices to control the flow rate. U.S. Pat. No. 4,926,852 relates to metering a dose of medication into a flow-through chamber that has orifices to limit the flow rate to control particle size. U.S. Pat. No. 3,658,059 discloses a baffle that changes the size of an aperture in the passage of the suspension being inhaled to select the quantity and size of particles delivered. A problem associated with these devices is that they process the aerosol after it is generated and are inefficient and wasteful.




To meet the requirements of administering a fluid in the form of an aerosol and to overcome the disadvantages of the prior art, it is an object of the present invention to provide an aerosol generator which vaporizes the fluid at a controlled flow rate regardless of the fluid's viscosity.




It is another object of the invention to obtain uniform vaporization of the fluid that is expelled from the aerosol generator.




It is a further object of the invention to provide a disposable aerosol generator which can deliver a metered dose of the fluid. By delivering individual single doses of medicated fluid it is possible to avoid contamination of the fluid, thereby negating the need for bacteriostatic compounds within the drug formulation.




It is yet another object of the invention to provide a disposable cartridge which can incorporate a package having therein multiple disposable aerosol generators, each of which provides a single shot delivery, as required by the user.




Other objects and aspects of the present invention will become apparent to one of ordinary skill in the art upon review of the specification, drawings and claims appended hereto.




SUMMARY OF THE INVENTION




According to one aspect of the invention, a disposable aerosol generator is provided which is adapted for use with an inhaler device which includes a heater arranged to volatilize fluid stored in the disposable aerosol generator. The aerosol generator comprises a disposable body having a sealed chamber and an outlet wherein first and second layers of material define the chamber. The chamber accommodates a predetermined volume of a fluid which is expelled through the outlet when the fluid in the chamber is volatilized by the heater.




According to another aspect of the invention, an inhaler device is provided which is usable with the disposable aerosol generator mentioned above, the inhaler device including a heater arranged to heat the fluid in the chamber so as to expel volatilized fluid from the outlet. The heater can comprise a layer of resistance heating material on a substrate which includes an opening located adjacent the outlet. In order to form the outlet, an opening device such as a piercing element can be provided which is adapted to pierce the first and/or second layer to form the outlet.




According to a further aspect of the invention, a method of using the inhaler device mentioned above is provided, the method including severing the first and/or second layer so as to form the outlet and activating the heater so as to volatilize the fluid in the chamber and expel the volatilized fluid through the outlet. According to a preferred method, the disposable body includes a series of spaced apart aerosol generators and the method includes moving the disposable body relative to the inhaler device so as to locate a first one of the aerosol generators at a position where the heater can heat the fluid in the chamber of the first aerosol generator and volatilize the fluid therein. The severing can be carried out by driving a piercing member through the first and/or second layer and the outlet can be located adjacent a passage of a dispensing member such that the volatilized fluid formed by the heater is expelled into the passage after passing through the outlet.











BRIEF DESCRIPTION OF THE DRAWINGS




The objects and advantages of the invention will become apparent from the following detailed description of the preferred embodiments thereof in connection with the accompanying drawing, in which:





FIGS. 1 and 2

show details of a disposable body containing a series of aerosol generators according to one embodiment of the invention,

FIG. 1

showing a top view thereof and

FIG. 2

showing a side view thereof;





FIG. 3

shows an inhaler device according to an embodiment of the invention;





FIG. 4

shows details of a heater of the inhaler device shown in

FIG. 3

;





FIG. 5

shows details of a first heater element pattern which can be used for a resistance heating layer of the heater shown in

FIG. 4

; and





FIG. 6

shows details of a second heater element pattern which can be used for a resistance heating layer of the heater shown in FIG.


4


.











DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS OF THE INVENTION




The present invention provides an inhaler effective for administering a fluid such as a medicated fluid in aerosol form. It has surprisingly and unexpectedly been determined that a metered amount of fluid can be delivered from the inhaler via a disposable aerosol generator wherein the fluid is fully vaporized and delivered at a predetermined flow rate.




With reference to

FIGS. 1 and 2

, an aerosol generator in accordance with one embodiment of the present invention is shown schematically. A single shot chamber or reservoir


10


is designed to accommodate a predetermined volume of fluid which can incorporate a medicament for treating various respiratory ailments (e.g., a partial list includes albuterol, isoproterenol sulfate, metaproterenol sulfate, terbutaline sulfate, pirbuterol acetate, salmeterol xinotoate, formotorol; steroids including beclomethasone dipropionate, flunisolide, fluticasone, budesonide and triamcinolone acetonide, beclomethasone dipropionate, triameinolone acetonide, flunisolide and fluticasone, etc.). Of course, the volume and composition of fluid may be predicated on the amount desired to treat a particular medical ailment.




An outlet


20


is in fluid communication with the chamber


10


and a heating member (not shown) disposed on or in proximate location to either chamber


10


and/or outlet


20


is operable to vaporize the fluid in the chamber


10


and eject the vaporized fluid out of the outlet


20


. For instance, a heating member may be employed in conjunction with both the chamber


10


and outlet


20


. In a preferred embodiment, the heater comprises part of a reusable inhaler device. However, the heater can be incorporated in the disposable body, e.g., a resistance heating element heated by passing current therethrough or by inductively heating the heating element.




In accordance with a preferred embodiment of the invention, chamber


10


is constructed from a material (e.g., polymeric, aluminum foil) resistant to heating. For example, in the embodiment shown in

FIGS. 1 and 2

, the chamber


10


is formed as a recess


12


in an injection molded body


14


of polymer material and a flow passage


30


comprises a channel


16


in the body


14


, the channel


16


extending from the recess


12


. The chamber


10


is sealed by a layer


18


such as aluminum foil heat sealed to the body


14


.




In order to provide multiple doses of medicated fluid in a disposable part of an inhaler, the body


14


can include a plurality of recesses


12


. The laminate thus described is capable of withstanding the pressure applied to the interior of the chamber through the application of heat necessary to vaporize the fluid contained therein. Outlet


20


is preferably a small aperture at the end of the flow passage


30


, the outlet being initially closed to the atmosphere. The flow passage


30


can have any suitable size which is effective to expel the vaporized fluid into the atmosphere and form the aerosol of desired particle size. For instance, flow passage


30


can have an inside diameter of about 0.05 to about 0.60 millimeter, preferably about 0.2 mm and a length of about 100 to 200 times the inside diameter. The chamber


10


can have any desired size such as a size suitable to deliver a single dose of medicated fluid, e.g., 5 μl.




In operation, the fluid in the chamber


10


is heated by a heating device which heats the fluid to a temperature sufficient to volatilize the fluid. In the case of an organic liquid material, the heating device preferably heats the fluid to approximately the boiling point, and preferably does not heat the fluid above 400° C., as most organic fluids are not stable when they are exposed to temperatures above 400° C.




Heating can be achieved in various ways including resistance or induction heating to heat the fluid via thermal conduction. Suitable heating devices envisioned for employment in the aerosol generator of the present invention include electrical resistance heaters, deposited resistance heating material such as thin platinum layers, electro-induction heating coils, etc. For example, the heating device can comprise an electrical resistance heater element arranged to thermally conduct heat into the chamber


10


. The heater can be any suitable material such as platinum, tungsten, molybdenum or metal alloy such as an iron-based alloy having 71.7% (by weight) iron, 23% chromium, and 5.3% aluminum.




The flow passage


30


can have any desired configuration. For instance, the flow passage can have a uniform cross-sectional area along the length thereof between the chamber


10


and the outlet


20


. However, the flow passage can vary in size along the length thereof, e.g., tapered so as to become more narrow in a direction towards the outlet


20


. Further, the chamber need not comprise a concave circular recess, but rather can comprise any desired configuration sized to accommodate a single dose of the medicated fluid.




According to a preferred embodiment, the heater device can comprise a layer of resistance heating material deposited on the outside of a support member such as a plastic or ceramic member, e.g., alumina, glass, titania, zirconia, or yttria-stabilized zirconia which does not experience oxidation at normal operating temperatures.




The heater support and the heater layer preferably have a roughly matching coefficient of thermal expansion to minimize thermally induced delamination. Also, the ceramic support material can have a surface roughness to improve adhesion of the deposited heater layer. Platinum is desirable as a heater material in that it is resistant to oxidation degradation or other corrosion.




The heater layer can be deposited as a thin film on a ceramic support such that the heater layer has a thickness of, e.g., less than approximately 2 μm. The heater layer can be deposited onto the ceramic by any suitable method such as DC magnetron sputter deposition, e.g., using an HRC magnetron sputter deposition unit, in argon at 8.0×10


−3


Torr. Alternatively, other conventional techniques such as vacuum evaporation, chemical deposition, electroless plating, electroplating, and chemical vapor deposition can be employed to apply the heater layer to the substrate. It will be appreciated by those skilled in the art, that the energy produced by the heating device can be distributed optimally by tailoring the pattern of the thin film. For example, the heater pattern can be arranged to provide more heat near the outlet


20


than in the vicinity of the recess


12


.




The closed end of the flow passage


20


can be opened by an opening device such as solenoid activated puncturing element. Alternatively, a cutting blade or scissors suitable for cutting the material sealing the flow passage


30


can be used to expel the volatilized fluid. It is further within the scope of the invention that other techniques such as a breakable seal can be employed on the closed end of the flow passage. The volatilized fluid can be expelled in a controlled manner taking into account properties of the fluid and the amount of heat needed to vaporize the fluid. The volatilized fluid can be expelled from the outlet


20


at a high velocity, e.g., approximately 90 m/s, but the volatilized fluid can be quickly dissipated in the atmosphere as the aerosol is formed from the condensing vapor, e.g., within about 2 mm of the outlet


20


. The volatilized fluid can be mixed with ambient air in an inhaler mouthpiece surrounding the outlet


20


, whereupon rapid cooling and condensation of the vapor result in formation of the aerosol.




The characteristics of the aerosol generated in accordance with the invention is a function of various parameters of the generator and the fluid provided. For aerosols intended for inhalation, for example, it is desirable for the aerosol to be approximately at body temperature when inhaled and for the mass media particles of the aerosol to be less than 2 microns, preferably between 0.5 and 1 micron.




Upon delivery of the metered amount of fluid, in aerosol form, the aerosol generator comprising the chamber


10


, outlet


20


and flow passage


30


can be discarded. In the case where multiple generators are provided in a multidose cartridge such as the disposable body shown in

FIGS. 1 and 2

, the cartridge can be disposed of when the last of the individual chambers have been emptied.




In accordance with another preferred embodiment, the heating device can comprise a plurality of heating members arranged to heat the fluid in the chamber and/or along the flow passage. Also, the fluid in the chamber could be expelled mechanically, e.g., by a member which pushes the fluid into the flow passage and a heater along the flow passage can be used to volatilize the fluid and expel the vaporized fluid out of the outlet


20


.




With reference to

FIGS. 3-6

, a fluid delivery system is depicted, wherein individual disposable aerosol generators are transported to a fluid release position as required by the user. The fluid delivery system


100


includes a cartridge


110


loaded with disposable aerosol generators


120


. In a preferred embodiment, the aerosol generators


120


are provided in the form of packets, preferably constructed as described above in connection with

FIGS. 1 and 2

. A heating device


130


provides sufficient energy to each generator


120


to vaporize the fluid and expel the vaporized fluid through a passage in a dispenser


140


. An opening device


150


can comprise a puncture element


152


activated by a solenoid


154


, the puncture element


152


being operable by a suitable controller and circuitry to penetrate the layer


18


in the vicinity of outlet


20


.




The heating device


130


includes an electrically resistive heating element


132


on a substrate


134


, the heating element


132


being powered by electrically conductive connections


136


extending through vias in the substrate


134


. The substrate


134


includes an opening


138


through which the piercing end of the puncture element


152


can move towards and away from the cartridge


110


. In operation, the controller can be activated to operate the system


100


so as to rotate the cartridge


110


to a drug release position, actuate the solenoid to drive the puncture arm towards the cartridge so as to pierce the channel


16


and thereby form the outlet


20


, and activate the heating element so as to heat the fluid in the chamber


10


whereby vaporized fluid is expelled through the dispenser


140


.





FIGS. 5 and 6

show embodiments of different heater patterns for the heater


130


. The heater


130




a


shown in

FIG. 5

includes a heating element


132




a


configured to completely cover the chamber


10


and flow passage


30


. With the heater element pattern shown in

FIG. 5

, greater heating can be achieved in the flow passage


30


due to the smaller cross sectional area of the heating element along the flow passage. The heater


132




b


shown in

FIG. 6

includes a heating element


132




b


configured as a sinusoidally shaped strip which overlies chamber


10


and a rectilinear strip which overlies the flow passage


20


.




In operation, the disposable cartridge


110


can be loaded into the inhaler


100


, and a transport mechanism (not shown) can be operated to successively transport the aerosol generators to the release position at which the heater volatilizes the fluid contained in the respective chamber. Driving power for the transport mechanism, the solenoid and the heating element can be provided by a power source such as a 9-volt battery. The dispenser


140


can be arranged to supply the vaporized fluid to a mouthpiece (not shown) of the inhaler


100


.




While the invention has been described in detail with reference to specific embodiments thereof, it will be apparent to those skilled in the art that various changes and modifications can be made, and equivalents employed, without departing from the scope of the appended claims.



Claims
  • 1. A disposable aerosol generator for use with an inhaler device which includes a heater adapted to volatilize fluid stored in the disposable aerosol generator, comprising:a disposable body including first and second layers of material and a series of spaced apart aerosol generators, each of the aerosol generators including a flow passage extending between a sealed chamber and an outlet which can be opened to expel volatilized fluid, the flow passage of each aerosol generator being located between the first and second layers, the disposable body being configured to fit in the inhaler device to allow advancement of each respective aerosol generator to a release position at which the fluid in the chamber of the respective aerosol generator can be heated, the chamber of each aerosol generator accommodating a predetermined volume of a fluid which is expelled as the volatilized fluid through the opened outlet when the fluid in the chamber is volatilized.
  • 2. An inhaler device usable with the disposable aerosol generator according to claim 1, wherein the inhaler device includes a heater arranged to heat the fluid in the chamber of each respective aerosol generator or a respective one of the aerosol generators so as to expel volatilized fluid from the opened outlet.
  • 3. The inhaler device according to claim 2, wherein the heater comprises an electrical resistance heater.
  • 4. The inhaler device according to claim 3, wherein the heater comprises a layer of resistance heating material on a substrate, the substrate including an opening located adjacent the outlet of each respective aerosol generator or a respective one of the aerosol generators.
  • 5. The inhaler device according to claim 2, further comprising an opening device, the opening device being adapted to pierce the first layer and/or second layer and open the outlet of each respective aerosol generator or a respective one of the aerosol generators.
  • 6. The inhaler device according to claim 5, wherein the opening device includes a solenoid activated piercing element, the piercing element including a movable tip which is located in the opening in the substrate, the tip being moved upon actuation of the piercing element such that the tip penetrates the first layer of the disposable body.
  • 7. The inhaler device according to claim 2, wherein the disposable body is movably supported such that the chamber of each respective aerosol generator or a respective one of the aerosol generators can be moved to a release position at which the heater can heat the fluid in the respective chamber sufficiently to volatilize the fluid to expel the volatilized fluid through the opened outlet.
  • 8. The inhaler device according to claim 4, wherein the layer of resistance heating material comprises a strip arranged in a pattern which is coextensive with the size of the chamber.
  • 9. The inhaler device according to claim 3, further comprising a dispensing member located adjacent the outlet of each respective aerosol generator or a respective one of the aerosol generators, the volatilized fluid expelled from the opened outlet passing through a passage in the dispensing member.
  • 10. The inhaler device according to claim 2, wherein the first layer comprises a layer of polymer material and the second layer of material comprises a foil heat sealed to the polymer layer, the inhaler device including an opening member which is operable to pierce the foil layer to open the outlet of each respective aerosol generator or a respective one of the aerosol generators immediately prior to when the heater is activated to volatilize the fluid in the chamber of the respective aerosol generator.
  • 11. The inhaler device according to claim 8, wherein the disposable body includes a flow passage extending rectilinearly from the chamber of each of the aerosol generators, the heater including a first portion arranged to heat the chamber and a second portion arranged to heat the flow passage of each respective aerosol generator or a respective one of the aerosol generators, the first and second portions of the heater comprising a layer of resistance heating material configured such that the second portion of the heater becomes hotter than the first portion of the heater during actuation of the heater to volatilize the fluid in the chamber of the respective aerosol generator.
  • 12. A method of forming an aerosol using the inhaler device according to claim 3, comprising severing the first and/or second layer so as to open the outlet of each respective aerosol generator or a respective one of the aerosol generators and activating the heater so as to volatilize the fluid in the chamber and expel the volatilized fluid through the opened outlet of the respective aerosol generator.
  • 13. The method according to claim 12, wherein the method comprises moving the disposable body relative to the inhaler device so as to locate a first one of the aerosol generators at a position where the heater can heat the fluid in the chamber of the first aerosol generator and volatilize the fluid therein.
  • 14. The method according to claim 12, wherein the severing is carried out by driving a piercing member through the first and/or second layer, the outlet of each respective aerosol generator or a respective one of the aerosol generators being located adjacent a passage of a dispensing member and the volatilized fluid formed by the heater being expelled into the passage after passing through the opened outlet.
  • 15. The method according to claim 14, wherein the disposable body includes a flow passage extending rectilinearly from the chamber of each of the aerosol generators, the heater including a first portion arranged to heat the chamber of each respective aerosol generator or a respective one of the aerosol generators and a second portion arranged to heat the flow passage of the respective aerosol generator, the first and second portions of the heater comprising a layer of resistance heating material configured such that the second portion of the heater becomes hotter than the first portion of the heater during volatilization of the fluid in the chamber.
  • 16. The aerosol generator according to claim 4, wherein each of the chambers contains a predetermined volume of a fluid including at least one medicament selected from the group consisting of albuterol, isoproterenol sulfate, metaproterenol sulfate, terbutaline sulfate, pirbuterol acetate, salmeterol xinotoate, formotorol, beclomethasone dipropionate, flunisolide, fluticasone, budesonide, triamcinolone acetonide, beclomethasone dipropionate, triamcinolone acetonide, flunisolide and fluticasone.
  • 17. The aerosol generator according to claim 12, wherein the fluid includes at least one medicament selected from the group consisting of albuterol, isoproterenol sulfate, metaproterenol sulfate, terbutaline sulfate, pirbuterol acetate, salmeterol xinotoate, formotorol, beclomethasone dipropionate, flunisolide, fluticasone, budesonide, triamcinolone acetonide, beclomethasone dipropionate, triamcinolone acetonide, flunisolide and fluticasone.
  • 18. An inhaler device, comprising:a disposable aerosol generator comprising a disposable body including a sealed chamber accommodating a fluid and a flow passage in communication with the chamber, the disposable body including first and second layers of material defining the chamber, the flow passage having an outlet which can be opened to expel volatilized fluid and having a diameter of from about 0.05 mm to about 0.60 mm; and a heater arranged to heat the fluid while in the chamber so as to expel volatilized fluid from the opened outlet.
  • 19. An inhaler device, comprising:a disposable aerosol generator comprising a disposable body including a sealed chamber accommodating a fluid and a flow passage in communication with the chamber, the disposable body including first and second layers of material defining the chamber, the flow passage having an outlet which can be opened to expel volatilized fluid and having a width of from about 0.05 mm to about 0.60 mm; and a heater arranged to heat the fluid while in the chamber so as to expel volatilized fluid from the opened outlet.
  • 20. The inhaler device according to claim 18, wherein the chamber contains a predetermined volume of a fluid including at least one medicament selected from the group consisting of albuterol, isoproterenol sulfate, metaproterenol sulfate, terbutaline sulfate, pirbuterol acetate, salmeterol xinotoate, formotorol, beclomethasone dipropionate, flunisolide, fluticasone, budesonide, triamcinolone acetonide, beclomethasone dipropionate, triamcinolone acetonide, flunisolide and fluticasone.
  • 21. The inhaler device according to claim 19, wherein the chamber contains a predetermined volume of a fluid including at least one medicament selected from the group consisting of albuterol, isoproterenol sulfate, metaproterenol sulfate, terbutaline sulfate, pirbuterol acetate, salmeterol xinotoate, formotorol, beclomethasone dipropionate, flunisolide, fluticasone, budesonide, triamcinolone acetonide, beclomethasone dipropionate, triamcinolone acetonide, flunisolide and fluticasone.
US Referenced Citations (197)
Number Name Date Kind
2896856 Kravits Jul 1959 A
3084698 Smith Apr 1963 A
3157179 Paullus et al. Nov 1964 A
3162324 Houser Dec 1964 A
3431393 Katsuda Mar 1969 A
3486663 Humphrey Dec 1969 A
3716416 Adlhart et al. Feb 1973 A
3750961 Franz Aug 1973 A
3847304 Cohen Nov 1974 A
3859398 Havstad Jan 1975 A
3902635 Jinotti Sep 1975 A
3903883 Pecina et al. Sep 1975 A
3904083 Little Sep 1975 A
3967001 Almaula et al. Jun 1976 A
3987941 Blessing Oct 1976 A
3993246 Erb et al. Nov 1976 A
4012471 Kunkle, Jr. Mar 1977 A
4012472 Lindsey Mar 1977 A
4012473 Lindsey et al. Mar 1977 A
4042153 Callahan et al. Aug 1977 A
4060082 Lindberg et al. Nov 1977 A
4077542 Petterson Mar 1978 A
4161282 Erb et al. Jul 1979 A
4162501 Mitchell et al. Jul 1979 A
4215708 Bron Aug 1980 A
4231492 Rios Nov 1980 A
4258073 Payne Mar 1981 A
4261356 Turner et al. Apr 1981 A
4289003 Yang Sep 1981 A
4291838 Williams Sep 1981 A
4303083 Burruss, Jr. Dec 1981 A
4383171 Sinha et al. May 1983 A
4391308 Steiner Jul 1983 A
4395303 Weir Jul 1983 A
4433797 Galia Feb 1984 A
4471892 Coleman Sep 1984 A
4512341 Lester Apr 1985 A
4575609 Fassel et al. Mar 1986 A
4649911 Knight et al. Mar 1987 A
4682010 Drapeau et al. Jul 1987 A
4695625 Macdonald Sep 1987 A
4700657 Butland Oct 1987 A
4730111 Vestal et al. Mar 1988 A
4735217 Gerth et al. Apr 1988 A
4744932 Browne May 1988 A
4749778 Fukuzawa et al. Jun 1988 A
4753352 Dauphin et al. Jun 1988 A
4762995 Browner et al. Aug 1988 A
4776515 Michalchik Oct 1988 A
4819625 Howe Apr 1989 A
4819834 Thiel Apr 1989 A
4829996 Noakes et al. May 1989 A
4837260 Sato et al. Jun 1989 A
4848374 Chard et al. Jul 1989 A
4871115 Hessey Oct 1989 A
4871623 Hoopman et al. Oct 1989 A
4877989 Drews et al. Oct 1989 A
4911157 Miller Mar 1990 A
4922901 Brooks et al. May 1990 A
4935624 Henion et al. Jun 1990 A
4941483 Ridings et al. Jul 1990 A
4947875 Brooks et al. Aug 1990 A
4974754 Wirz Dec 1990 A
4982097 Slivon et al. Jan 1991 A
4992206 Waldron Feb 1991 A
5021802 Allred Jun 1991 A
5044565 Alexander Sep 1991 A
5056511 Ronge Oct 1991 A
5060671 Counts et al. Oct 1991 A
5063921 Howe Nov 1991 A
5096092 Devine Mar 1992 A
5125441 Mette Jun 1992 A
5133343 Johnson, IV et al. Jul 1992 A
5134993 van der Linden et al. Aug 1992 A
5135009 Müller et al. Aug 1992 A
5144962 Counts et al. Sep 1992 A
5151827 Ven et al. Sep 1992 A
5178305 Keller Jan 1993 A
5184776 Minier Feb 1993 A
5217004 Blasnik et al. Jun 1993 A
5226441 Dunmire et al. Jul 1993 A
5228444 Burch Jul 1993 A
5230445 Rusnak Jul 1993 A
5231983 Matson et al. Aug 1993 A
5259370 Howe Nov 1993 A
5290540 Prince et al. Mar 1994 A
5298744 Mimura et al. Mar 1994 A
5299565 Brown Apr 1994 A
5322057 Raabe et al. Jun 1994 A
5327915 Porenski et al. Jul 1994 A
5342180 Daoud Aug 1994 A
5342645 Eisele et al. Aug 1994 A
5349946 McComb Sep 1994 A
5395445 Bohanan Mar 1995 A
5421489 Holzner, Sr. et al. Jun 1995 A
5462597 Jubran Oct 1995 A
5474059 Cooper Dec 1995 A
5515842 Ramseyer et al. May 1996 A
5522385 Lloyd et al. Jun 1996 A
5556964 Hofstraat et al. Sep 1996 A
5564442 MacDonald et al. Oct 1996 A
5565677 Wexler Oct 1996 A
5575929 Yu et al. Nov 1996 A
5585045 Heinonen et al. Dec 1996 A
5617844 King Apr 1997 A
5642728 Andersson et al. Jul 1997 A
5674860 Carling et al. Oct 1997 A
5682874 Grabenkort et al. Nov 1997 A
5730158 Collins et al. Mar 1998 A
5756995 Maswadeh et al. May 1998 A
5765724 Amberg et al. Jun 1998 A
5792422 Lin et al. Aug 1998 A
5839430 Cama Nov 1998 A
5855202 Andrade Jan 1999 A
5856671 Henion et al. Jan 1999 A
5863652 Matsumura et al. Jan 1999 A
5869133 Anthony et al. Feb 1999 A
5872010 Karger et al. Feb 1999 A
5878752 Adams et al. Mar 1999 A
5881714 Yokoi et al. Mar 1999 A
5906202 Schuster et al. May 1999 A
5914122 Otterbeck et al. Jun 1999 A
5932249 Gruber et al. Aug 1999 A
5932315 Lum et al. Aug 1999 A
5934272 Lloyd et al. Aug 1999 A
5934273 Andersson et al. Aug 1999 A
5944025 Cook et al. Aug 1999 A
5954979 Counts et al. Sep 1999 A
5957124 Lloyd et al. Sep 1999 A
5970973 Gonda et al. Oct 1999 A
5970974 Van Der Linden et al. Oct 1999 A
5978548 Holmstrand et al. Nov 1999 A
5993633 Smith et al. Nov 1999 A
6014970 Ivri et al. Jan 2000 A
6053176 Adams et al. Apr 2000 A
6054032 Haddad et al. Apr 2000 A
6069214 McCormick et al. May 2000 A
6069219 McCormick et al. May 2000 A
6070575 Gonda et al. Jun 2000 A
6071428 Franks et al. Jun 2000 A
6076522 Dwivedi et al. Jun 2000 A
6077543 Gordon et al. Jun 2000 A
6080721 Patton Jun 2000 A
6085740 Ivri et al. Jul 2000 A
6085753 Gonda et al. Jul 2000 A
6089228 Smith et al. Jul 2000 A
6095153 Kessler et al. Aug 2000 A
6098615 Lloyd et al. Aug 2000 A
6098620 Lloyd et al. Aug 2000 A
6103270 Johnson et al. Aug 2000 A
6116516 Gañán-Calvo Sep 2000 A
6116893 Peach Sep 2000 A
6119953 Gañán-Calvo et al. Sep 2000 A
6123068 Lloyd et al. Sep 2000 A
6123936 Platz et al. Sep 2000 A
6131567 Gonda et al. Oct 2000 A
6131570 Schuster et al. Oct 2000 A
6136346 Eljamal et al. Oct 2000 A
6138668 Patton et al. Oct 2000 A
6155268 Takeuchi Dec 2000 A
6158431 Poole Dec 2000 A
6158676 Hughes Dec 2000 A
6159188 Laibovitz et al. Dec 2000 A
6164630 Birdsell et al. Dec 2000 A
6165463 Platz et al. Dec 2000 A
6167880 Gonda et al. Jan 2001 B1
6174469 Gañán-Calvo Jan 2001 B1
6182712 Stout et al. Feb 2001 B1
6187214 Gañán-Calvo Feb 2001 B1
6187344 Eljamal et al. Feb 2001 B1
6189803 Gañán-Calvo Feb 2001 B1
6192882 Gonda Feb 2001 B1
6197835 Gañán-Calvo Mar 2001 B1
6205999 Ivri et al. Mar 2001 B1
6206242 Amberg et al. Mar 2001 B1
6207135 Rössling et al. Mar 2001 B1
6223746 Jewett et al. May 2001 B1
6230706 Gonda et al. May 2001 B1
6231851 Platz et al. May 2001 B1
6234167 Cox et al. May 2001 B1
6234402 Gañán-Calvo May 2001 B1
6235177 Borland et al. May 2001 B1
6250298 Gonda et al. Jun 2001 B1
6250301 Pate Jun 2001 B1
6257233 Burr et al. Jul 2001 B1
6258341 Foster et al. Jul 2001 B1
6263872 Schuster et al. Jul 2001 B1
6267155 Parks et al. Jul 2001 B1
6275650 Lambert Aug 2001 B1
6276347 Hunt Aug 2001 B1
6284525 Mathies et al. Sep 2001 B1
6288360 Beste Sep 2001 B1
6290685 Insley et al. Sep 2001 B1
6294204 Rössling et al. Sep 2001 B1
6295986 Patel et al. Oct 2001 B1
6318361 Sosiak Nov 2001 B1
20010032647 Schuster et al. Oct 2001 A1
Foreign Referenced Citations (7)
Number Date Country
0358114 Mar 1990 EP
0642802 May 1996 EP
168128 Nov 1977 HU
216121 Mar 1991 HU
P953409 Jun 1994 HU
9409842 May 1994 WO
9817131 Apr 1998 WO
Non-Patent Literature Citations (13)
Entry
Notification of Transmittal of the International Search Report or the Declaration dated Mar. 6, 2003 for PCT/US02/38910.
Written Opinion dated Nov. 4, 2003 for PCT/US01/44809.
Notification of Transmittal of the International Search Report or the Declaration for PCT/US01/44809 dated May 8, 2003.
Written Opinion dated Dec. 24, 2003 for PCT/US02/38910.
Barry, P.W. et al. “In Vitro Comparison of the Amount of Salbutamol Available for Inhalation From Different Formulations Used with Different Spacer Devices” Eur Respir J 1997; 10: 1345-1348.
Byron, Peter R. Ph.D., Chairman, “Recommendations of the USP Advisory Panel on Aerosols on the USP General Chapters on Aerosols (601) and Uniformity of Dosage Units (905)”, Pharmacopeial Forum, vol. 20, No. 3, pp. 7477-7505, May-Jun. 1994 (023).
Hindle, Michael et al., “High Efficiency Aerosol Production Using the Capillary Aerosol Generator” PharmSci 1998; 1: (1: suppl) S211.
Hindle, Michael et al., “High Efficiency Fine Particle Generation Using Novel Condensation Technology”, Respiratory Drug Delivery VI (eds Dalby, R.N., Byron, P.R. & Farr, S.J.) Interpharm Press, Buffalo Grove, IL 1998 pp 97-102.
Hou, Shuguang et al. Solution Stability of Budensonide in Novel Aerosol Formulations Abstract No. 2582, Solid State Physical Pharmacy, Nov. 17, 1998, p. S-307.
Kousaka, Yasuo et al., “Generation of Aerosol Particles by Boiling of Suspensions”, Aerosol Science and Technology, 21:236-240 (1994) (023).
Morén, Folke “Drug Deposition of Pressurized Inhalation Aerosols I. Influence of Actuator Tube Design” AB Draco (Subsidiary of AB Astra, Sweden) Research and Development Laboratories Pack, S-221 01 Lund (Sweden), International Journal of Pharmaceutrics, 1 (1978) 205-212.
Newman, Stephen P. et al. “Deposition of Pressurized Suspension Aerosols Inhaled Through Extension Devices1-3” Am Rev Respir Dis 1981; 124:317-320.
Roth, G. et al. High Performance Liquid Chromatographic Determination of Epimers, Impurities, and Content of the Glucocorticoid Budesonide and Preparation of Primary Standard, Journal of Pharmaceutical Sciences, vol. 69, No. 7, pp. 766-770, Jul. 1980.